Related Experiment Video
Updated: Aug 20, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Neurocognitive outcomes in survivors of childhood cancer
1University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA. bmoore@mdanderson.org
Objective:
s To review issues associated with neurocognitive outcome in survivors of pediatric cancer. Recommendations are made for future research directions.
Methods:
A large body of literature pertaining to neurocognitive outcome in cancer survivors was reviewed. Brain development and methodological issues that provide challenges to conducting meaningful research in cancer outcomes also are discussed.
Results:
Neurotoxic agents used in some cancer therapies produce permanent neurocognitive sequelae, especially in very young children.
Conclusions:
The state of neurocognitive research for pediatric cancer survivors needs to move beyond empirical studies of neurocognitive sequelae to research that will identify individual patients at risk for neurocognitive morbidity.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Treatment Resistent Cancers
Psychoneuroimmunology: Diabetes and Cancer
Cognitive Development During Adulthood
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...